At Edmonton Startup Week, CAAIN's Douglas Mills, Nanostics' Colin Coros, University of Alberta's David Bressler, and BJ Fuchs made the case that the AgTech sector is fertile ground for innovation.
Edmonton Startup Week panelists say AgTech could power the next tech boom | BetaKit
Industry leaders point to agriculture’s appetite for new tech and its real-world problems that need solutions.
betakit.com
October 9, 2026 at 6:01 PM
At Edmonton Startup Week, CAAIN's Douglas Mills, Nanostics' Colin Coros, University of Alberta's David Bressler, and BJ Fuchs made the case that the AgTech sector is fertile ground for innovation.
Nanostics Unveils ClarityDX Prostate Study with New Algorithms for Cancer Prediction#Canada#Edmonton#Prostate_Cancer#ClarityDX_Prostate#Nanostics
Nanostics Unveils ClarityDX Prostate Study with New Algorithms for Cancer Prediction
Nanostics has published a groundbreaking study on its ClarityDX Prostate platform, featuring new AI algorithms for cancer diagnosis, making MRIs optional.
third-news.com
April 20, 2026 at 12:50 PM
Nanostics Unveils ClarityDX Prostate Study with New Algorithms for Cancer Prediction#Canada#Edmonton#Prostate_Cancer#ClarityDX_Prostate#Nanostics
Genome Canada Financial Support Boosts ClarityDX Prostate Testing Across Canada#Canada#Edmonton#ClarityDX_Prostate#Nanostics#Genome_Canada
Genome Canada Financial Support Boosts ClarityDX Prostate Testing Across Canada
This article discusses the significant investment by Genome Canada to facilitate the adoption of ClarityDX Prostate, an innovative cancer diagnostic technology, in Canadian healthcare.
third-news.com
June 26, 2025 at 3:44 PM
Genome Canada Financial Support Boosts ClarityDX Prostate Testing Across Canada#Canada#Edmonton#ClarityDX_Prostate#Nanostics#Genome_Canada
Nanostics Launches New Study to Enhance Early Detection of Prostate Cancer Using AI Technology#Canada#Calgary#Prostate_Cancer#ClarityDX_Prostate#Nanostics
Nanostics Launches New Study to Enhance Early Detection of Prostate Cancer Using AI Technology
Nanostics is moving forward with a clinical utility study aimed at improving prostate cancer detection using its ClarityDX Prostate test, targeting a reduction in unnecessary biopsies.
third-news.com
April 23, 2025 at 2:35 PM
Nanostics Launches New Study to Enhance Early Detection of Prostate Cancer Using AI Technology#Canada#Calgary#Prostate_Cancer#ClarityDX_Prostate#Nanostics
Nanostics Achieves CPSA Accreditation for New Clinical Lab Location in Edmonton's Biotechnology Hub#Canada#Edmonton#Nanostics_Inc#ClarityDX_Prostate#CPSA_Accreditation
Nanostics Achieves CPSA Accreditation for New Clinical Lab Location in Edmonton's Biotechnology Hub
Nanostics Inc. has received provisional CPSA accreditation for its new clinical lab at the Biotechnology Business Development Centre in Edmonton, enhancing prostate cancer diagnostics.
third-news.com
April 16, 2025 at 12:28 PM
Nanostics Achieves CPSA Accreditation for New Clinical Lab Location in Edmonton's Biotechnology Hub#Canada#Edmonton#Nanostics_Inc#ClarityDX_Prostate#CPSA_Accreditation
